icd11-codes-cs
type: CodeSystem
node role: treeRoot
id:
  v: icd11-codes-cs
text:
  status:
    v: generated
  div:
    v: Generated Narrative: CodeSystem icd11-codes-cs This case-sensitive code system https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs defines the following codes: Code Display mms ICD-11 for Mortality and Morbidity Statistics 1630407678 Neoplasms 1766440644 Diseases of the blood or blood-forming organs 1954798891 Diseases of the immune system 1435254666 Certain infectious or parasitic diseases 21500692 Endocrine, nutritional or metabolic diseases 2A00-2A0Z Neoplasms of central nervous system or related structures 2B50-2E2Z Malignant neoplasms, except primary neoplasms of lymphoid, haematopoietic, central nervous system or related tissues 2A20-2B3Z Neoplasms of haematopoietic or lymphoid tissues 2E60-2E6Z In situ neoplasms, except of lymphoid, haematopoietic, central nervous system or related tissues 2E80-2F3Z Benign neoplasms, except of lymphoid, haematopoietic, central nervous system or related tissues 2E62 Carcinoma in situ of middle ear or respiratory system 2E61 Carcinoma in situ of other or unspecified digestive organs 2E60 Carcinoma in situ of oral cavity, oesophagus or stomach 2E90-2F3Z Benign neoplasms except of mesenchymal origin 2E80-2E8Z Benign mesenchymal neoplasms 1B70-1B7Z Pyogenic bacterial infections of the skin or subcutaneous tissues 1B10-1B2Z Mycobacterial diseases 1A60-1A9Z Predominantly sexually transmitted infections 1A00-1A40.Z Gastroenteritis or colitis of infectious origin 2E64 Carcinoma in situ of skin 2E63 Melanoma in situ neoplasms 1B40-1B5Z Certain staphylococcal or streptococcal diseases 5B50-5C3Z Nutritional disorders 5C50-5D2Z Metabolic disorders 5D40-5D46 Postprocedural endocrine or metabolic disorders 5A00-5B3Z Endocrine diseases 2E81 Benign vascular neoplasms 2E84 Benign fibrogenic or myofibrogenic tumour 2E80 Benign lipomatous neoplasm 2E92 Benign neoplasm of digestive organs 2E90 Benign neoplasm of lip, oral cavity or pharynx 2F00-2F01 Benign neoplasm of middle ear, respiratory or intrathoracic organs 2E91 Benign neoplasm of m…
url:
  v: https://nshr-uat.sha.go.ke/fhir/CodeSystem/icd11-codes-cs
  l: icd11-codes-cs
version:
  v: 0.1.0
name:
  v: ICD11CodesCS
title:
  v: ICD-11 Code System
status:
  v: active
experimental:
  v: false
date:
  v: 2026-05-31T12:18:58+00:00
publisher:
  v: DHA, Kenya
contact:
  name:
    v: DHA, Kenya
  telecom:
    system:
      v: url
    value:
      v: https://dha.go.ke/
  telecom:
    system:
      v: email
contact:
  name:
    v: Digital Health Agency, Kenya
  telecom:
    system:
      v: email
    use:
      v: work
  telecom:
    system:
      v: url
    value:
      v: https://www.dha.go.ke/
description:
  v: ICD-11 codes for mortality and morbidity statistics. Source: MOH-KENYA OCL ICD-11-FOR-MORTALITY-AND-MORBIDITY-STATISTICS.
jurisdiction:
  coding:
    system:
      v: urn:iso:std:iso:3166
      l: 3166
    code:
      v: KE
    display:
      v: Kenya
copyright:
  v: Copyright 2025+ Digital Health Agency, Kenya. This content is licensed under Creative Commons Attribution 4.0 International (CC-BY-4.0). Terminology content from the Kenya Pharmacy and Poisons Board (PPB) via Open Concept Lab (OCL) is subject to separate terms.
case sensitive:
  v: true
content:
  v: complete
count:
  v: 1000
concept:
  code:
    v: mms
  display:
    v: ICD-11 for Mortality and Morbidity Statistics
concept:
  code:
    v: 1630407678
  display:
    v: Neoplasms
concept:
  code:
    v: 1766440644
  display:
    v: Diseases of the blood or blood-forming organs
concept:
  code:
    v: 1954798891
  display:
    v: Diseases of the immune system
concept:
  code:
    v: 1435254666
  display:
    v: Certain infectious or parasitic diseases
concept:
  code:
    v: 21500692
  display:
    v: Endocrine, nutritional or metabolic diseases
concept:
  code:
    v: 2A00-2A0Z
  display:
    v: Neoplasms of central nervous system or related structures
concept:
  code:
    v: 2B50-2E2Z
  display:
    v: Malignant neoplasms, except primary neoplasms of lymphoid, haematopoietic, central nervous system or related tissues
concept:
  code:
    v: 2A20-2B3Z
  display:
    v: Neoplasms of haematopoietic or lymphoid tissues
concept:
  code:
    v: 2E60-2E6Z
  display:
    v: In situ neoplasms, except of lymphoid, haematopoietic, central nervous system or related tissues
concept:
  code:
    v: 2E80-2F3Z
  display:
    v: Benign neoplasms, except of lymphoid, haematopoietic, central nervous system or related tissues
concept:
  code:
    v: 2E62
  display:
    v: Carcinoma in situ of middle ear or respiratory system
concept:
  code:
    v: 2E61
  display:
    v: Carcinoma in situ of other or unspecified digestive organs
concept:
  code:
    v: 2E60
  display:
    v: Carcinoma in situ of oral cavity, oesophagus or stomach
concept:
  code:
    v: 2E90-2F3Z
  display:
    v: Benign neoplasms except of mesenchymal origin
concept:
  code:
    v: 2E80-2E8Z
  display:
    v: Benign mesenchymal neoplasms
concept:
  code:
    v: 1B70-1B7Z
  display:
    v: Pyogenic bacterial infections of the skin or subcutaneous tissues
concept:
  code:
    v: 1B10-1B2Z
  display:
    v: Mycobacterial diseases
concept:
  code:
    v: 1A60-1A9Z
  display:
    v: Predominantly sexually transmitted infections
concept:
  code:
    v: 1A00-1A40.Z
  display:
    v: Gastroenteritis or colitis of infectious origin
concept:
  code:
    v: 2E64
  display:
    v: Carcinoma in situ of skin
concept:
  code:
    v: 2E63
  display:
    v: Melanoma in situ neoplasms
concept:
  code:
    v: 1B40-1B5Z
  display:
    v: Certain staphylococcal or streptococcal diseases
concept:
  code:
    v: 5B50-5C3Z
  display:
    v: Nutritional disorders
concept:
  code:
    v: 5C50-5D2Z
  display:
    v: Metabolic disorders
concept:
  code:
    v: 5D40-5D46
  display:
    v: Postprocedural endocrine or metabolic disorders
concept:
  code:
    v: 5A00-5B3Z

v: Endocrine diseases

code:
  v: 2E81
display:
  v: Benign vascular neoplasms

code:
  v: 2E84
display:
  v: Benign fibrogenic or myofibrogenic tumour

code:
  v: 2E80
display:
  v: Benign lipomatous neoplasm

code:
  v: 2E92
display:
  v: Benign neoplasm of digestive organs

code:
  v: 2E90
display:
  v: Benign neoplasm of lip, oral cavity or pharynx

code:
  v: 2F00-2F01
display:
  v: Benign neoplasm of middle ear, respiratory or intrathoracic organs

code:
  v: 2E91
display:
  v: Benign neoplasm of major salivary glands

code:
  v: 1B10-1B1Z
display:
  v: Tuberculosis

code:
  v: 2F10
display:
  v: Fibrous benign mesothelioma of omentum

code:
  v: 2E83
display:
  v: Benign osteogenic tumours

code:
  v: 1B74
display:
  v: Superficial bacterial folliculitis

code:
  v: 2D50-2E2Z
display:
  v: Malignant neoplasm metastases

code:
  v: 1B70
display:
  v: Bacterial cellulitis, erysipelas or lymphangitis

code:
  v: 1B71
display:
  v: Necrotising fasciitis

code:
  v: 1A20-1A2Z
display:
  v: Viral intestinal infections

code:
  v: 1A30-1A3Z
display:
  v: Protozoal intestinal infections

code:
  v: 1B72
display:
  v: Impetigo

code:
  v: 1B73
display:
  v: Ecthyma

code:
  v: 2E82
display:
  v: Benign chondrogenic tumours

code:
  v: 2D40-2D4Z
display:
  v: Malignant neoplasms of ill-defined or unspecified primary sites

code:
  v: 2B50-2D3Z
display:
  v: Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic, central nervous system or related tissues

code:
  v: 1B21
display:
  v: Infections due to non-tuberculous mycobacteria

code:
  v: 1B20
display:
  v: Leprosy

code:
  v: 2E63.0
display:
  v: Melanoma in situ of skin

code:
  v: 1B2Y
display:
  v: Other specified mycobacterial diseases

code:
  v: 1B54
display:
  v: Staphylococcal spinal meningitis

code:
  v: 1B50
display:
  v: Otitis media in scarlet fever

code:
  v: 1B53
display:
  v: Meningitis due to Streptococcus agalactiae

code:
  v: 1B40-1B42
display:
  v: Acute rheumatic fever

code:
  v: 1B51
display:
  v: acute streptococcal ulcerated sore throat

code:
  v: 1A00-1A0Z
display:
  v: Bacterial intestinal infections

code:
  v: 1A10-1A1Z
display:
  v: Bacterial foodborne intoxications

code:
  v: 2E63.1
display:
  v: Melanoma in situ of conjunctiva

code:
  v: 2E63.Y
display:
  v: Melanoma in situ neoplasms, other specified site

code:
  v: 1B2Z
display:
  v: Mycobacterial diseases, unspecified

code:
  v: 2E63.Z
display:
  v: precancerous melanosis of unspecified site

code:
  v: 1A40
display:
  v: Gastroenteritis or colitis without specification of infectious agent

code:
  v: 4A60-4A6Z
display:
  v: Autoinflammatory disorders

code:
  v: 4A20
display:
  v: Acquired immunodeficiencies

code:
  v: 4A80-4A8Z
display:
  v: Allergic or hypersensitivity conditions

code:
  v: 4A40-4A4Z
display:
  v: Nonorgan specific systemic autoimmune disorders

code:
  v: 4A00-4A0Z
display:
  v: Primary immunodeficiencies

code:
  v: 2E61.3
display:
  v: gallbladder carcinoma in situ

code:
  v: 2E60.2
display:
  v: Carcinoma in situ of intraepithelium of stomach

code:
  v: 2E60.1
display:
  v: Glandular intraepithelial neoplasia of oesophagus, high grade

code:
  v: 2E61.0
display:
  v: Carcinoma in situ of rectosigmoid junction

code:
  v: 2E61.2
display:
  v: AIN - [anal intraepithelial neoplasia] high grade

code:
  v: 2E61.1
display:
  v: Intraepithelial neoplasia (dysplasia) of rectum, high grade

code:
  v: 2E61.Y
display:
  v: Carcinoma in situ of tail of pancreas

code:
  v: 2E62.2
display:
  v: pulmonary carcinoma in situ

code:
  v: 2E62.Z
display:
  v: Carcinoma in situ of middle ear or respiratory system

code:
  v: 2E62.Y
display:
  v: Carcinoma in situ of vestibule of nose

code:
  v: 2E62.0
display:
  v: Carcinoma in situ of thyroid cartilage

code:
  v: 2E60.0
display:
  v: Carcinoma in situ upper labial sulcus

code:
  v: 2E62.1
display:
  v: Intraepithelial neoplasia (dysplasia) of trachea, high grade

code:
  v: 2A00
display:
  v: Primary neoplasms of brain

code:
  v: 2A02
display:
  v: Primary neoplasm of spinal cord, cranial nerves, paraspinal nerves or remaining parts of central nervous system

code:
  v: 2A0Z
display:
  v: Nonpolyposis Turcot syndrome

code:
  v: 2A01
display:
  v: primary neoplasm of spinal meninges

code:
  v: 5B50-5B7Z
display:
  v: Undernutrition

code:
  v: 5C3Y
display:
  v: Skin disorder attributable to food fads or unhealthy diet

code:
  v: 5C3Z
display:
  v: Nutritional liver disease, not elsewhere classified

code:
  v: 2E64.0
display:
  v: Intraepidermal squamous cell carcinoma

code:
  v: 5B80-5C1Z
display:
  v: Overweight, obesity or specific nutrient excesses

code:
  v: 2E64.Z
display:
  v: skin carcinoma in situ

code:
  v: 2E64.1
display:
  v: Extramammary Paget disease of anogenital skin

code:
  v: 2E64.Y
display:
  v: Apocrine adenocarcinoma in situ of unspecified site

code:
  v: 2E64.2
display:
  v: High grade squamous intraepithelial lesion of anal margin or perianal skin

code:
  v: 5D40
display:
  v: Postprocedural hypothyroidism

code:
  v: 5D41
display:
  v: Postpancreatectomy hyperglycaemia

code:
  v: 5A50-5A5Z
display:
  v: Disorders of the parathyroids or parathyroid hormone system

code:
  v: 5D42
display:
  v: Parathyroprival tetany

code:
  v: 5D43
display:
  v: Postirradiation hypopituitarism

code:
  v: 5D44
display:
  v: iatrogenic ovarian failure

code:
  v: 5A40-5A4Z
display:
  v: Other disorders of glucose regulation or pancreatic internal secretion

code:
  v: 5A10-5A2Y
display:
  v: Diabetes mellitus

code:
  v: 5A60-5A6Z
display:
  v: Disorders of the pituitary hormone system

code:
  v: 5A00-5A0Z
display:
  v: Disorders of the thyroid gland or thyroid hormones system

code:
  v: 2E84.0
display:
  v: Benign fibrogenic or myofibrogenic tumour of skin

code:
  v: 2E84.Z
display:
  v: Myxoma of unspecified site

code:
  v: 2E84.Y
display:
  v: Benign fibrogenic or myofibrogenic tumour of other specified sites

code:
  v: 2E80.Y
display:
  v: Other specified benign lipomatous neoplasm

code:
  v: 2E80.1
display:
  v: Lipoblastoma

code:
  v: 2E80.0
display:
  v: Lipoma

code:
  v: 2E80.Z
display:
  v: Benign adipocytic tumour

code:
  v: 2E92.4
display:
  v: Benign neoplasm of the large intestine

code:
  v: 2E92.2
display:
  v: Other benign neoplasm of duodenum

code:
  v: 2E92.1
display:
  v: benign tumour of pylorus

code:
  v: 2F00
display:
  v: Benign neoplasm of middle ear or respiratory system

code:
  v: 2E90.3
display:
  v: Benign tumour of internal cheek

code:
  v: 2E92.0
display:
  v: benign tumour of upper third of oesophagus

code:
  v: 2E92.3
display:
  v: benign tumour of ileal diverticulum

code:
  v: 2E83.2
display:
  v: benign neoplasm of vertebra

code:
  v: 2E90.2
display:
  v: benign tumour of floor of mouth

code:
  v: 2E83.3
display:
  v: benign neoplasm of clavicle

code:
  v: 2E90.1
display:
  v: Granular cell myoblastoma of tongue

code:
  v: 2E90.4
display:
  v: benign tumour of tonsil

code:
  v: 1B71.0
display:
  v: Necrotising fasciitis type 2

code:
  v: 2E90.0
display:
  v: Benign tumour of upper labial mucosa

code:
  v: 2F01
display:
  v: Benign neoplasm of visceral pleura

code:
  v: 2E83.0
display:
  v: Upper jaw dentinoma

code:
  v: 2F20-2F2Z
display:
  v: Benign cutaneous neoplasms

code:
  v: 2E83.1
display:
  v: Periradicular cemental dysplasia of lower jaw

code:
  v: 2E83.4
display:
  v: Benign neoplasm of sacrum

code:
  v: 2D70-2D7Z
display:
  v: Malignant neoplasm metastasis in thoracic or respiratory organs

code:
  v: 1B74.Z
display:
  v: Superficial folliculitis

code:
  v: 1B74.0
display:
  v: Follicular impetigo of Bockhart

code:
  v: 1B71.1
display:
  v: Progressive bacterial synergistic gangrene

code:
  v: 1B71.2
display:
  v: Neonatal streptococcal necrotising fasciitis

code:
  v: 2D52
display:
  v: Malignant neoplasm metastasis in epidural space

code:
  v: 2D60-2D6Z
display:
  v: Malignant neoplasm metastasis in lymph nodes

code:
  v: 2D50
display:
  v: Malignant neoplasm metastasis in choroid plexus

code:
  v: 1B71.Z
display:
  v: necrotizing fasciitis

code:
  v: 2D51
display:
  v: spinal arachnoid metastasis

code:
  v: 1B71.Y
display:
  v: Necrotising fasciitis, trunk

code:
  v: 1A31
display:
  v: Colitis due to Giardia lamblia

code:
  v: 1A33
display:
  v: Cystoisosporiasis

code:
  v: 1B74.Y
display:
  v: Hot tub folliculitis

code:
  v: 1A34
display:
  v: sarcosporidiasis

code:
  v: 2E82.0
display:
  v: Benign chondrogenic tumours of bone or articular cartilage of limbs

code:
  v: 1A32
display:
  v: Cryptosporidial colitis

code:
  v: 1A30
display:
  v: Balantidium coli anaemia

code:
  v: 2E82.Z
display:
  v: giant cell chondromatous tumour of unspecified site

code:
  v: 2C30-2C3Z
display:
  v: Malignant neoplasms of skin

code:
  v: 2B70-2C1Z
display:
  v: Malignant neoplasms of digestive organs

code:
  v: 2E82.1
display:
  v: Benign chondrogenic tumours of bone or articular cartilage of other specified sites

code:
  v: 1B73.Z
display:
  v: Ecthyma

code:
  v: 1B73.2
display:
  v: Ecthyma gangrenosum

code:
  v: 1B73.1
display:
  v: Staphylococcal ecthyma

code:
  v: 1B73.0
display:
  v: Streptococcal ecthyma

code:
  v: 2B60-2B6Y
display:
  v: Malignant neoplasms of lip, oral cavity or pharynx

code:
  v: 2C20-2C2Z
display:
  v: Malignant neoplasms of middle ear, respiratory or intrathoracic organs

code:
  v: 1B73.Y
display:
  v: Other specified ecthyma

code:
  v: 2B50-2B5Z
display:
  v: Malignant mesenchymal neoplasms

code:
  v: 1B20.2
display:
  v: Leprosy reactions

code:
  v: 1B20.3
display:
  v: Mycobacterium leprae dacryoadenitis

code:
  v: 1B20.Z
display:
  v: leprosy unspecified

code:
  v: 1B20.1
display:
  v: Hansen disease, diffuse lepromatous

code:
  v: 2E63.00
display:
  v: Hutchinson melanotic freckle

code:
  v: 2E63.0Z
display:
  v: Radial growth phase malignant melanoma

code:
  v: 1B5Y
display:
  v: Staphylococcal pericarditis

code:
  v: 1B20.0
display:
  v: BT - [borderline tuberculoid] leprosy

code:
  v: 1B40
display:
  v: Acute rheumatic fever without mention of heart involvement

code:
  v: 1B41
display:
  v: Acute rheumatic fever with heart involvement

code:
  v: 1B42
display:
  v: ST Vitus dance

code:
  v: 1B5Z
display:
  v: sepsis due to group B Strep without mention of septic shock

code:
  v: 4A61
display:
  v: SAPHO - [synovitis, acne, pustulosis, hyperostosis, osteitis] syndrome

code:
  v: 4A6Z
display:
  v: Autoinflammatory disorders, unspecified

code:
  v: 4A6Y
display:
  v: Juvenile chronic recurrent multifocal osteomyelitis

code:
  v: 4A60
display:
  v: Monogenic autoinflammatory syndromes

code:
  v: 4A20.1
display:
  v: Acquired immunodeficiency due to protein loss

code:
  v: 4A62
display:
  v: Neurological complications of Behçet disease

code:
  v: 4A20.Z
display:
  v: Acquired immunodeficiencies

code:
  v: 4A20.Y
display:
  v: Other specified acquired immunodeficiencies

code:
  v: 4A84
display:
  v: Anaphylaxis

code:
  v: 4A80
display:
  v: Allergic or hypersensitivity disorders involving the respiratory tract

code:
  v: 4A20.0
display:
  v: Adult-onset immunodeficiency

code:
  v: 4A83
display:
  v: Allergic or hypersensitivity disorders involving the gastrointestinal tract

code:
  v: 4A82
display:
  v: Arthus phenomenon

code:
  v: 4A81
display:
  v: Ocular allergy

code:
  v: 4A41
display:
  v: Idiopathic inflammatory myopathy

code:
  v: 4A43
display:
  v: Overlap or undifferentiated nonorgan specific systemic autoimmune disease

code:
  v: 4A42
display:
  v: Systemic sclerosis

code:
  v: 4A44
display:
  v: Vasculitis

code:
  v: 4A40
display:
  v: Lupus erythematosus

code:
  v: 2E61.Z
display:
  v: Carcinoma in situ of other or unspecified digestive organs

code:
  v: 4A0Y
display:
  v: Lymphocyte function antigen-1 [LFA-1] defect

code:
  v: 4A0Z
display:
  v: Primary immunodeficiencies, unspecified

code:
  v: 4A01
display:
  v: Primary immunodeficiencies due to disorders of adaptive immunity

code:
  v: 4A00
display:
  v: Primary immunodeficiencies due to disorders of innate immunity

code:
  v: 1A90
display:
  v: Chancroidal lymphadenitis

code:
  v: 1A91
display:
  v: Osteomyelitis due to Klebsiella granuloma inguinale

code:
  v: 1A70-1A7Z
display:
  v: Gonococcal infection

code:
  v: 1A60-1A6Z
display:
  v: Syphilis

code:
  v: 1A80-1A8Z
display:
  v: Sexually transmissible infections due to chlamydia

code:
  v: 2A00.3
display:
  v: Central neurocytoma of brain

code:
  v: 2A00.4
display:
  v: astroblastoma of unspecified site

code:
  v: 2A00.2
display:
  v: Tumours of neuroepithelial tissue of brain

code:
  v: 2A00.1
display:
  v: Embryonal tumours of brain

code:
  v: 2A00.0
display:
  v: Gliomas of brain

code:
  v: 2A02.4
display:
  v: Benign neoplasm of cauda equina

code:
  v: 2A02.0
display:
  v: Gliomas of spinal cord, cranial or paraspinal nerves

code:
  v: 2A02.2
display:
  v: primary malignant neoplasm of cauda equina

code:
  v: 2A01.0
display:
  v: Meningiomas

code:
  v: 2A02.1
display:
  v: Tumours of cranial or paraspinal nerves

code:
  v: 2A02.3
display:
  v: acoustic neurinoma

code:
  v: 2A01.2
display:
  v: Neoplasm of uncertain or unknown behaviour of spinal meninges

code:
  v: 2A01.1
display:
  v: Mesenchymal tumours of meninges

code:
  v: 2A20-2A2Z
display:
  v: Myeloproliferative neoplasms

code:
  v: 2A40-2A4Z
display:
  v: Myelodysplastic and myeloproliferative neoplasms

code:
  v: 2A60
display:
  v: Acute myeloid leukaemias and related precursor neoplasms

code:
  v: 2A30-2A3Z
display:
  v: Myelodysplastic syndromes

code:
  v: 2A50-2A5Z
display:
  v: Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB or FGFR1

code:
  v: 2E91.0
display:
  v: benign tumour of parotid gland

code:
  v: 2E91.Z
display:
  v: Warthin tumour of unspecified site

code:
  v: 1B12
display:
  v: Tuberculosis of other systems and organs

code:
  v: 1B13
display:
  v: Miliary tuberculosis

code:
  v: 1B11
display:
  v: Tuberculosis of the nervous system

code:
  v: 2E91.1
display:
  v: Benign neoplasm of submaxillary gland

code:
  v: 1B14
display:
  v: Carrier of Mycobacterium tuberculosis

code:
  v: 1B10
display:
  v: Tuberculosis of the respiratory system

code:
  v: 1B70.0
display:
  v: Erysipelas

code:
  v: 1B70.2
display:
  v: Staphylococcal cellulitis of skin

code:
  v: 1B70.3
display:
  v: Ascending bacterial lymphangitis due to Staphylococcus aureus

code:
  v: 1B70.Y
display:
  v: Bacterial cellulitis or lymphangitis due to other specified bacterium

code:
  v: 1B70.1
display:
  v: Streptococcal cellulitis of the vulva and vagina

code:
  v: 1A22
display:
  v: rotaviral enteritis

code:
  v: 1A20
display:
  v: Adenoviral enteritis

code:
  v: 1A24
display:
  v: Gastroenteritis due to Cytomegalovirus

code:
  v: 1A21
display:
  v: infections due to Astrovirus

code:
  v: 2D44
display:
  v: metastatic cancer, unknown origin, so stated

code:
  v: 2D41
display:
  v: Metastatic carcinoma [primary carcinoma spreading elsewhere]

code:
  v: 1A23
display:
  v: Noroviral enteritis

code:
  v: 2D43
display:
  v: Malignant neoplasms of independent, multiple primary sites

code:
  v: 2D40
display:
  v: Villous adenocarcinoma in adenoma of unspecified site

code:
  v: 2D42
display:
  v: calf cancer

code:
  v: 2E64.00
display:
  v: Bowen type intraepidermal squamous cell carcinoma

code:
  v: 2E64.0Y
display:
  v: Other specified intraepidermal squamous cell carcinoma

code:
  v: 2E64.01
display:
  v: Intraepidermal squamous cell carcinoma arising from actinic keratosis

code:
  v: 2E64.0Z
display:
  v: IEC - [intraepidermal carcinoma]

code:
  v: 5B90-5B9Z
display:
  v: Certain specified nutrient excesses

code:
  v: 5B80-5B81.Z
display:
  v: Overweight or obesity

code:
  v: 5C1Z
display:
  v: Overweight, obesity or specific nutrient excesses, unspecified

code:
  v: 5C1Y
display:
  v: late effect of hyperalimentation

code:
  v: 5D40.Y
display:
  v: Other specified postprocedural hypothyroidism

code:
  v: 5D40.0
display:
  v: Postirridation hypothyroidism

code:
  v: 5D40.Z
display:
  v: hypothyroidism due to absence of thyroid

code:
  v: 5D45
display:
  v: Postprocedural testicular hypofunction

code:
  v: 5D46
display:
  v: adrenalectomy status

code:
  v: 5A60
display:
  v: Hyperfunction of pituitary gland

code:
  v: 5A61
display:
  v: hypothalamic lesion

code:
  v: 5A6Z
display:
  v: Disorders of the pituitary hormone system, unspecified

code:
  v: 5A11
display:
  v: insulin resistant diabetes

code:
  v: 5A10
display:
  v: SPIDDM - [Slowly progressive insulin-dependent diabetes mellitus]

code:
  v: 5A13
display:
  v: Other specified Diabetes mellitus, not Type 1 and not Type 2

code:
  v: 5A14
display:
  v: Diabetes without mention of type of diabetes mellitus

code:
  v: 5A00
display:
  v: Hypothyroidism

code:
  v: 5A02
display:
  v: Thyrotoxicosis

code:
  v: 5A12
display:
  v: malnutrition-related diabetes mellitus without complications

code:
  v: 5A04
display:
  v: C-cell hyperplasia of thyroid

code:
  v: 5A03
display:
  v: Thyroiditis

code:
  v: 5A01
display:
  v: Nontoxic goitre

code:
  v: 2E85
display:
  v: Benign fibrohistiocytic tumour

code:
  v: 2E80.00
display:
  v: Superficial subcutaneous lipoma

code:
  v: 2E80.0Y
display:
  v: Lipoma, other specified site

code:
  v: 2E80.01
display:
  v: Benign lipoma of spermatic cord

code:
  v: 2E80.02
display:
  v: Deep internal benign lipoma of retroperitoneum

code:
  v: 2E80.0Z
display:
  v: Spindle cell lipoma of unspecified site

code:
  v: 2E92.4Z
display:
  v: benign tumor of large intestine

code:
  v: 2E92.40
display:
  v: HMPS - [hereditary mixed polyposis syndrome]

code:
  v: 2E92.4Y
display:
  v: Tubular adenoma of sigmoid

code:
  v: 2F00.Z
display:
  v: Benign neoplasm of middle ear or respiratory system

code:
  v: 2F00.0
display:
  v: Middle ear neuroendocrine tumour

code:
  v: 2F00.1
display:
  v: Recurrent respiratory papillomatosis

code:
  v: 2E92.5
display:
  v: Benign anorectal neoplasm

code:
  v: 2E92.6
display:
  v: Other benign neoplasms of gallbladder, extrahepatic bile duct or ampulla of Vater

code:
  v: 2F00.2
display:
  v: Laryngeal neuroendocrine tumour

code:
  v: 2E92.7
display:
  v: biliary ductal cystadenoma

code:
  v: 2F00.Y
display:
  v: Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia

code:
  v: 2E90.5
display:
  v: Benign tumour of mesopharynx

code:
  v: 2E83.5
display:
  v: Benign neoplasm of patella

code:
  v: 2E90.6
display:
  v: Benign neoplasm of the pharyngeal tonsil

code:
  v: 2F21
display:
  v: Benign keratinocytic acanthomas

code:
  v: 2F20
display:
  v: Benign cutaneous melanocytic neoplasms

code:
  v: 2F23
display:
  v: Benign dermal fibrous or fibrohistiocytic neoplasms

code:
  v: 2F24
display:
  v: Cellular neurothekeoma

code:
  v: 2E83.Y
display:
  v: Benign osteogenic tumour of other specified site

code:
  v: 2D71
display:
  v: mediastinum metastasis

code:
  v: 2D72
display:
  v: pleural metastasis

code:
  v: 2D7Y
display:
  v: tracheal cartilage metastasis

code:
  v: 2F22
display:
  v: Tubular papillary adenoma

code:
  v: 2D70
display:
  v: Metastatic carcinoma in lung

code:
  v: 2D73
display:
  v: Malignant neoplasm metastasis in false vocal cord

code:
  v: 2E83.Z
display:
  v: Osteoma of unspecified site

code:
  v: 2D90-2D91
display:
  v: Malignant neoplasm metastasis in retroperitoneum or peritoneum

code:
  v: 2D80-2D8Z
display:
  v: Malignant neoplasm metastasis in digestive system

code:
  v: 2E00-2E0Y
display:
  v: Malignant neoplasm metastasis in other specified sites

code:
  v: 1A33.0
display:
  v: Infection due to Isopora belli

code:
  v: 1A33.1
display:
  v: coccidial colitis

code:
  v: 1B75
display:
  v: Deep bacterial folliculitis or pyogenic abscess of the skin

code:
  v: 1A35
display:
  v: Blastocystosis

code:
  v: 1A33.Y
display:
  v: Other specified cystoisosporiasis

code:
  v: 1A36
display:
  v: Amoebiasis

code:
  v: 1A33.Z
display:
  v: Isosporiasis

code:
  v: 1A3Z
display:
  v: Protozoal intestinal infections, unspecified

code:
  v: 1A3Y
display:
  v: embadomonas dysentery

code:
  v: 2E86
display:
  v: Benign smooth muscle or skeletal muscle tumour

code:
  v: 1B7Y
display:
  v: Skin infection classified elsewhere due to hospital-acquired MRSA

code:
  v: 1B20.20
display:
  v: Leprosy upgrading reaction

code:
  v: 1B20.21
display:
  v: Lucio phenomenon

code:
  v: 2E65
display:
  v: Carcinoma in situ of breast

code:
  v: 1B40.0
display:
  v: acute articular rheumatism

code:
  v: 1B40.Z
display:
  v: subacute rheumatic fever

code:
  v: 1B40.Y
display:
  v: rheumatic pneumonitis

code:
  v: 2E81.Y
display:
  v: Other specified benign vascular neoplasms

code:
  v: 2E81.2
display:
  v: Benign vascular neoplasms of infancy or childhood

code:
  v: 2E81.0
display:
  v: Neoplastic haemangioma

code:
  v: 2E81.Z
display:
  v: Benign vascular neoplasms

code:
  v: 2E81.1
display:
  v: Benign lymphatic neoplasms

code:
  v: 4A60.2
display:
  v: Tumour necrosis factor receptor 1 associated periodic syndrome with amyloidosis

code:
  v: 4A60.1
display:
  v: Muckle Wells Syndrome with neurosensorial hearing loss

code:
  v: 4A60.0
display:
  v: Familial Mediterranean fever with amyloidosis

code:
  v: 4A60.Z
display:
  v: Monogenic autoinflammatory syndromes

code:
  v: 4A60.Y
display:
  v: NLRP12-associated hereditary periodic fever syndrome

code:
  v: 4A84.0
display:
  v: Anaphylactic shock due to allergic food reaction

code:
  v: 4A84.3
display:
  v: Anaphylaxis provoked by physical factors

code:
  v: 4A84.2
display:
  v: Insect venom allergen-induced anaphylaxis

code:
  v: 4A84.4
display:
  v: Inhaled allergen-induced anaphylaxis

code:
  v: 4A84.1
display:
  v: medicament-induced anaphylaxis

code:
  v: 4B00-4B0Z
display:
  v: Immune system disorders involving white cell lineages

code:
  v: 4A80.Y
display:
  v: Other specified allergic or hypersensitivity disorders involving the respiratory tract

code:
  v: 4A80.1
display:
  v: Food-induced wheezing

code:
  v: 4A80.Z
display:
  v: Allergic or hypersensitivity disorders involving the respiratory tract

code:
  v: 4A80.0
display:
  v: medicament-induced bronchospasm

code:
  v: 4A83.1
display:
  v: Food-induced eosinophilic oesophagitis

code:
  v: 4A83.Y
display:
  v: Other specified allergic or hypersensitivity disorders involving the gastrointestinal tract

code:
  v: 4A83.Z
display:
  v: Allergic or hypersensitivity disorders involving the gastrointestinal tract

code:
  v: 4A83.0
display:
  v: Food-induced eosinophilic gastroenteritis

code:
  v: 4A85
display:
  v: Complex allergic or hypersensitivity conditions

code:
  v: 4A8Y
display:
  v: Allergic or hypersensitivity conditions of other specified type

code:
  v: 4A41.0
display:
  v: Dermatomyositis

code:
  v: 4A41.Y
display:
  v: Focal myositis

code:
  v: 4A41.2
display:
  v: Inclusion body myopathy

code:
  v: 4A41.1
display:
  v: Polymyositis

code:
  v: 4A41.Z
display:
  v: Idiopathic inflammatory myopathy

code:
  v: 4A43.2
display:
  v: Sjögren syndrome

code:
  v: 4A43.3
display:
  v: Paediatric-onset MCTD - [mixed connective tissue disease]

code:
  v: 4A44.2
display:
  v: Giant cell arteritis without polymyalgia rheumatica

code:
  v: 4A43.1
display:
  v: Mikulicz disease

code:
  v: 4A43.0
display:
  v: Cholangitis of IgG4-related sclerosing disease

code:
  v: 4A43.4
display:
  v: Diffuse fasciitis

code:
  v: 4A40.1
display:
  v: drug-induced systemic lupus erythematosus

code:
  v: 4A44.0
display:
  v: Rhizomelic pseudopolyarthritis

code:
  v: 4A44.3
display:
  v: Single organ vasculitis

code:
  v: 4A40.Y
display:
  v: Lupus erythematosus of oral mucosa

code:
  v: 4A40.0
display:
  v: Systemic lupus erythematosus

code:
  v: 4A44.4
display:
  v: Periarteritis nodosa with necrosis

code:
  v: 4A44.1
display:
  v: young female aortic arch arteritis syndrome

code:
  v: 4A40.Z
display:
  v: LE - [lupus erythematosus]

code:
  v: 4A01.1
display:
  v: Combined immunodeficiencies

code:
  v: 4A01.2
display:
  v: Diseases of immune dysregulation

code:
  v: 4A01.0
display:
  v: Immunodeficiencies with predominantly antibody defects

code:
  v: 4A01.Z
display:
  v: Primary immunodeficiencies due to disorders of adaptive immunity

code:
  v: 4A01.3
display:
  v: Other well-defined immunodeficiency syndromes due to defects in adaptive immunity

code:
  v: 4A00.1
display:
  v: Defects in the complement system

code:
  v: 4A00.3
display:
  v: Immunodeficiency with NK-cell - [natural-killer cell] deficiency

code:
  v: 4A00.Y
display:
  v: Warts - hypogammaglobulinaemia - infections - myelokathexis

code:
  v: 4A00.2
display:
  v: Pyogenic bacterial infections due to MyD88 deficiency

code:
  v: 4A00.0
display:
  v: Functional neutrophil defects

code:
  v: 1A93
display:
  v: Sexually transmissible infestations

code:
  v: 1A92
display:
  v: Trichomonal cervicitis

code:
  v: 1A60
display:
  v: Congenital syphilis

code:
  v: 1A61
display:
  v: Early syphilis

code:
  v: 1A63
display:
  v: Positive Wassermann test

code:
  v: 1A6Z
display:
  v: Female syphilitic pelvic inflammatory disease

code:
  v: 1A62
display:
  v: Late syphilis

code:
  v: 1B72.0
display:
  v: Blistering distal dactylitis

code:
  v: 1B72.Y
display:
  v: Other specified impetigo

code:
  v: 1B72.1
display:
  v: Non-bullous impetigo

code:
  v: 1B21.1
display:
  v: Non-tuberculous mycobacterial lymphadenitis

code:
  v: 1B21.0
display:
  v: Pulmonary infection due to Mycobacterium malmoense

code:
  v: 1B21.4
display:
  v: Non-tuberculous mycobacterial colitis

code:
  v: 2A00.20
display:
  v: Pineocytoma

code:
  v: 2A00.21
display:
  v: Lhermitte-Duclos disease

code:
  v: 2A00.22
display:
  v: choroid plexus carcinoma (grade 3 lesion)

code:
  v: 2A00.2Y
display:
  v: Other specified tumours of neuroepithelial tissue of brain

code:
  v: 2A00.0Z
display:
  v: glioma NOS

code:
  v: 2A00.2Z
display:
  v: Tumours of neuroepithelial tissue of brain

code:
  v: 2A00.5
display:
  v: benign brain tumour NOS

code:
  v: 2A00.1Y
display:
  v: Yolk sac tumour of the central nervous system

code:
  v: 1B21.3
display:
  v: DMAC - [disseminated mycobacterium avium-intracellulare complex infection]

code:
  v: 2A02.00
display:
  v: Glioblastoma of spinal cord, cranial or paraspinal nerves

code:
  v: 2A02.0Z
display:
  v: Gliomas of spinal cord, cranial or paraspinal nerves

code:
  v: 2A02.0Y
display:
  v: Malignant astrocytomas of spinal cord, cranial or paraspinal nerves

code:
  v: 2A00.00
display:
  v: Spongioblastoma multiforme of unspecified site

code:
  v: 2A00.10
display:
  v: Neuroepithelioma

code:
  v: 2A00.1Z
display:
  v: Embryonal tumours of brain

code:
  v: 2A00.0Y
display:
  v: Subependymal glioma, unspecified site

code:
  v: 2A02.10
display:
  v: neurofibrosarcoma

code:
  v: 2A00.11
display:
  v: Teratoid medulloepithelioma of unspecified site

code:
  v: 2A20
display:
  v: Non mast cell myeloproliferative neoplasms

code:
  v: 2A60.4
display:
  v: Myeloid proliferation associated with Down syndrome

code:
  v: 2A60.1
display:
  v: Acute myeloid leukaemia with multilineage dysplasia in complete remission

code:
  v: 2A60.2
display:
  v: Therapy-related myeloid neoplasms

code:
  v: 2A40
display:
  v: CMML-2 - [chronic myelomonocytic leukaemia Type 2]

code:
  v: 2A60.0
display:
  v: Acute myeloid leukemia with t(8;21)(q22;q22) translocation

code:
  v: 2A41
display:
  v: Atypical chronic myeloid leukaemia, BCR-ABL1-negative in complete remission

code:
  v: 1B12.2
display:
  v: Tuberculosis of inner ear

code:
  v: 1B12.0
display:
  v: tuberculous pericarditis

code:
  v: 2A01.0Z
display:
  v: benign meningioma (deprecated)

code:
  v: 2A2Z
display:
  v: myeloproliferative disorder

code:
  v: 1B1Y
display:
  v: Disorders of kidney or ureter in tuberculosis

code:
  v: 1B11.1
display:
  v: Tuberculous meningoencephalitis

code:
  v: 2A60.3
display:
  v: Acute myeloid leukaemia, not elsewhere classified by criteria of other types

code:
  v: 1B11.2
display:
  v: Tuberculoma of spinal meninges

code:
  v: 2A43
display:
  v: RARS-T [Refractory anaemia with ringed sideroblasts associated with marked thrombocytosis](provisional)

code:
  v: 2A42
display:
  v: Juvenile myelomonocytic leukaemia

code:
  v: 2A44
display:
  v: Myeloproliferative and myelodysplastic disease, unclassifiable in complete remission

code:
  v: 2A51
display:
  v: Myeloid neoplasms with PDGFRB rearrangement

code:
  v: 2A02.Z
display:
  v: Epidural cancer NOS

code:
  v: 1B13.2
display:
  v: Acute miliary tuberculosis, unspecified site

code:
  v: 1B13.1
display:
  v: tuberculous polyserositis

code:
  v: 1B13.Y
display:
  v: Chronic multiple tuberculosis

code:
  v: 1B13.Z
display:
  v: disseminated tuberculosis

code:
  v: 1B11.3
display:
  v: tuberculoma of brain

code:
  v: 1B11.0
display:
  v: spinal meningeal TBC - [tuberculosis]

code:
  v: 1B11.Y
display:
  v: tuberculous cerebrum arteritis

code:
  v: 2A01.0Y
display:
  v: Syncytial meningioma of unspecified site

code:
  v: 2A2Y
display:
  v: chronic myeloproliferative disease NOS

code:
  v: 1A40.0
display:
  v: jejunal inflammation

code:
  v: 2E92.8
display:
  v: benign tumour of tail of pancreas

code:
  v: 1A40.Z
display:
  v: intestinal infections without specification of infectious agent

code:
  v: 1B13.0
display:
  v: Acute miliary lung TBC - [tuberculosis]

code:
  v: 2F30
display:
  v: Benign neoplasm of breast

code:
  v: 1B10.0
display:
  v: Tuberculous sinusitis of any sinus, with bacteriological and histological confirmation

code:
  v: 1B7Z
display:
  v: suppurative dermatitis

code:
  v: 1B12.5
display:
  v: Tuberculosis of breast

code:
  v: 1B10.Z
display:
  v: Tuberculous pansinusitis

code:
  v: 2D61
display:
  v: Malignant neoplasm metastasis in lymph nodes of multiple regions by adenocarcinoma

code:
  v: 2D6Z
display:
  v: lymphatic vessel metastasis

code:
  v: 1B70.Z
display:
  v: Cellulitis not otherwise specified

code:
  v: 2E81.2Y
display:
  v: Diffuse neonatal haemangiomatosis

code:
  v: 2E90.7
display:
  v: Benign tumour of pharyngoesophageal junction

code:
  v: 1A2Z
display:
  v: Viral gastroenteropathy NOS

code:
  v: 2E81.21
display:
  v: Multiple strawberry haemangiomata

code:
  v: 1B12.6
display:
  v: TB - [tuberculosis] axillary gland

code:
  v: 2B63
display:
  v: Malignant neoplasms of gum

code:
  v: 2B64
display:
  v: Malignant neoplasms of floor of mouth

code:
  v: 2B61
display:
  v: Malignant neoplasms of base of tongue

code:
  v: 2E66
display:
  v: Carcinoma in situ of cervix uteri

code:
  v: 2D60
display:
  v: Malignant neoplasm metastasis in lymph node of a single region

code:
  v: 5B80
display:
  v: Overweight or localised adiposity

code:
  v: 5B81
display:
  v: Obesity

code:
  v: 5B90
display:
  v: Vitamin excesses

code:
  v: 1A2Y
display:
  v: Enteritis due to coxsackievirus

code:
  v: 1B12.8
display:
  v: Tuberculous gumma

code:
  v: 5A05
display:
  v: Refetoff syndrome

code:
  v: 2F20.Y
display:
  v: Unclassifiable benign cutaneous melanocytic proliferation

code:
  v: 5B91
display:
  v: Mineral excesses

code:
  v: 5B9Z
display:
  v: Nutrient excesses, unspecified

code:
  v: 2D4Z
display:
  v: Cancer in polyp

code:
  v: 2B60
display:
  v: Malignant neoplasms of lip

code:
  v: 2B62
display:
  v: Malignant neoplasms of other or unspecified parts of tongue

code:
  v: 5A00.0
display:
  v: Congenital hypothyroidism

code:
  v: 5A00.Z
display:
  v: Subclinical hypothyroidism

code:
  v: 5A00.1
display:
  v: Iodine-deficiency-related thyroid disorders or allied conditions

code:
  v: 5A20-5A2Y
display:
  v: Acute complications of diabetes mellitus

code:
  v: 4A43.Y
display:
  v: Other specified non-organ specific systemic autoimmune disorders, not elsewhere classified, associated with anti-RNP antibodies

code:
  v: 2E87
display:
  v: GIST - [gastrointestinal stromal tumour] of appendix

code:
  v: 5D40.0Z
display:
  v: Postirridation hypothyroidism

code:
  v: 2F20.2
display:
  v: Congenital melanocytic naevus

code:
  v: 2F20.3
display:
  v: Generalised eruptive melanocytic naevi

code:
  v: 2F20.1
display:
  v: Melanocytic naevus with mild to moderate dysplasia

code:
  v: 2F20.Z
display:
  v: Naevus pigmentosus

code:
  v: 5B9Y
display:
  v: Other specified nutrient excesses

code:
  v: 2E92.Y
display:
  v: Benign neoplasm of other specified digestive organs

code:
  v: 4A42.Z
display:
  v: Myopathy in scleroderma

code:
  v: 2F21.0
display:
  v: Traumatized seborrhoeic keratosis

code:
  v: 2F25
display:
  v: de Morgan's spots

code:
  v: 2F23.0
display:
  v: Subepidermal nodular fibrosis

code:
  v: 2F23.Y
display:
  v: Fibrous papule of nose

code:
  v: 2E90.8
display:
  v: benign tumour of Waldeyer ring

code:
  v: 2E88
display:
  v: Stromal nodule

code:
  v: 2E92.Z
display:
  v: benign tumour of intestine NOS

code:
  v: 4A42.2
display:
  v: CRST - [calcinosis, Raynaud phenomenon, sclerodactyly and telangiectasia] syndrome

code:
  v: 2D80
display:
  v: Secondary malignant neoplasm of liver or intrahepatic bile duct

code:
  v: 2D84
display:
  v: duodenal metastasis

code:
  v: 2D82
display:
  v: metastasis to ductus choledochus

code:
  v: 2F26
display:
  v: Pyogenic granuloma

code:
  v: 1A70
display:
  v: Gonococcal genitourinary infection

code:
  v: 2D90
display:
  v: secondary malignant neoplasm of retroperitoneum

code:
  v: 1B75.0
display:
  v: Boil

code:
  v: 1B75.2
display:
  v: Furunculosis

code:
  v: 2D91
display:
  v: malignant ascites NOS

code:
  v: 4A01.30
display:
  v: Immunodeficiency due to absence of thymus

code:
  v: 4A01.32
display:
  v: Schimke syndrome

code:
  v: 2E86.2
display:
  v: Glycogenic rhabdomyoma

code:
  v: 1A72
display:
  v: Gonococcal infection of other sites

code:
  v: 1A36.Z
display:
  v: amoebiasis, unspecified

code:
  v: 1A7Z
display:
  v: Infection due to Neisseria gonorrhoeae

code:
  v: 2D7Z
display:
  v: thorax metastasis

code:
  v: 4A01.33
display:
  v: VODI - [Veno-occlusive disease immunodeficiency] syndrome

code:
  v: 4A01.31
display:
  v: ATLD - [Ataxia-telangiectasia-like disorder]

code:
  v: 4A01.34
display:
  v: Hyperimmunoglobulin E syndrome due to TYK2 deficiency

code:
  v: 2E86.Z
display:
  v: myoma of unspecified site

code:
  v: 1A36.0
display:
  v: Intestinal infections due to Entamoeba

code:
  v: 2D86
display:
  v: anal canal metastasis

code:
  v: 1B75.3
display:
  v: abscess NOS

code:
  v: 1B75.1
display:
  v: Carbuncle

code:
  v: 3A00-3A9Z
display:
  v: Anaemias or other erythrocyte disorders

code:
  v: 2A30
display:
  v: refractory anaemia without sideroblasts

code:
  v: 3B10-3B6Z
display:
  v: Coagulation defects, purpura or other haemorrhagic or related conditions

code:
  v: 3B80-3B8Z
display:
  v: Diseases of spleen

code:
  v: 2A01.00
display:
  v: Familial multiple meningioma

code:
  v: 1A10
display:
  v: staphylococcus poisoning

code:
  v: 1A00
display:
  v: Cholera due to Vibrio cholerae O139

code:
  v: 1B21.2
display:
  v: Cutaneous non-tuberculous mycobacterial infection

code:
  v: 1A71
display:
  v: Gonococcal ovarian abscess

code:
  v: 1A12
display:
  v: pigbel

code:
  v: 2B50
display:
  v: Chondrosarcoma, primary site

code:
  v: 2A32
display:
  v: Refractory thrombocytopenia

code:
  v: 2A31
display:
  v: Refractory neutropaenia

code:
  v: 2B52
display:
  v: Ewing sarcoma, primary site

code:
  v: 1A70.0
display:
  v: Gonococcal infection of lower genitourinary tract without periurethral or accessory gland abscess

code:
  v: 2A21
display:
  v: Mastocytosis

code:
  v: 1A70.1
display:
  v: Gonococcal abscess of penis

code:
  v: 1A02
display:
  v: Sepsis due to shigella with septic shock

code:
  v: 1A81
display:
  v: Non-ulcerative sexually transmitted chlamydial infection

code:
  v: 1A60.1
display:
  v: Early congenital syphilis, latent

code:
  v: 1A8Y
display:
  v: Other specified sexually transmissible infections due to chlamydia

code:
  v: 1A01
display:
  v: Infections due to Vibrio vulnificus

code:
  v: 1A80
display:
  v: chlamydial lymphogranuloma venereum

code:
  v: 1B10.1
display:
  v: tuberculous pleural effusion, not confirmed

code:
  v: 1A11
display:
  v: Botulism

code:
  v: 1A72.1
display:
  v: Infection of the rectum due to Neisseria gonorrhoeae

code:
  v: 1A72.2
display:
  v: Infection of the anus due to Neisseria gonorrhoeae

code:
  v: 2A02.11
display:
  v: paraspinous neuroblastoma

code:
  v: 1A70.Y
display:
  v: Chronic gonococcal prostatitis

code:
  v: 2B71
display:
  v: Malignant neoplasms of oesophagogastric junction

code:
  v: 1A72.0
display:
  v: Gonococcal spondylitis

code:
  v: 1A61.1
display:
  v: primary syphilis of anus

code:
  v: 2B72
display:
  v: Malignant neoplasms of stomach

code:
  v: 2A02.12
display:
  v: Other specified malignant neoplasms of optic nerve

code:
  v: 2B70
display:
  v: Malignant neoplasms of oesophagus

code:
  v: 2A42.0
display:
  v: Juvenile myelomonocytic leukaemia in complete remission

code:
  v: 2A20.0
display:
  v: Chronic myelogenous leukaemia, BCR-ABL1-positive

code:
  v: 1A61.2
display:
  v: primary syphilitic tonsils

code:
  v: 1B21.Y
display:
  v: mycobacteriosis NOS

code:
  v: 2A20.1
display:
  v: Chronic neutrophilic leukaemia

code:
  v: 2A20.2
display:
  v: megakaryocytic myeloid metaplasia

code:
  v: 2A4Y
display:
  v: Other specified myelodysplastic and myeloproliferative neoplasms

code:
  v: 2A02.1Y
display:
  v: Olfactory groove meningioma

code:
  v: 2D4Y
display:
  v: Small cell carcinoma of unspecified site

code:
  v: 2A4Z
display:
  v: Myelodysplastic and myeloproliferative neoplasms, unspecified

code:
  v: 2B62.0
display:
  v: Squamous cell carcinoma of tongue NOS

code:
  v: 2B51
display:
  v: Osteosarcoma, primary site

code:
  v: 2D60.2
display:
  v: spleen lymph gland metastasis

code:
  v: 1A60.2
display:
  v: Late congenital syphilitic chorioretinitis

code:
  v: 1B12.4
display:
  v: Tuberculosis of the musculoskeletal system

code:
  v: 2D81
display:
  v: secondary malignant neoplasm of pancreas

code:
  v: 1B21.Z
display:
  v: MOTT - [mycobacteria other than tubercle bacilli]

code:
  v: 1A61.0
display:
  v: Urethral chancre

code:
  v: 1A60.0
display:
  v: Early congenital visceral syphilis

code:
  v: 2A42.Z
display:
  v: juvenile myelomonocytic leukaemia without mention of remission

code:
  v: 2A42.Y
display:
  v: Other specified juvenile myelomonocytic leukaemia

code:
  v: 2B61.Y
display:
  v: Other specified malignant neoplasms of base of tongue

code:
  v: 1B12.1
display:
  v: Tuberculous chorioretinitis

code:
  v: 1A62.1
display:
  v: Syphilitic pulmonary aneurysm

code:
  v: 2B61.0
display:
  v: Squamous cell carcinoma of the base of the tongue

code:
  v: 2D60.0
display:
  v: Supraclavicular lymph gland metastasis

code:
  v: 2B62.1
display:
  v: Malignant neoplasms of lingual tonsil

code:
  v: 1A62.2
display:
  v: Symptomatic late syphilis of other sites

code:
  v: 1A62.0
display:
  v: Neurosyphilis

code:
  v: 2B60.1
display:
  v: Squamous cell carcinoma of lip

code:
  v: 2D60.1
display:
  v: Pulmonary lymph gland metastasis

code:
  v: 2B61.Z
display:
  v: malignant neoplasm of anterior two-thirds of tongue, dorsal surface

code:
  v: 2D83
display:
  v: secondary malignant neoplasm of hepatopancreatic ampulla

code:
  v: 2B60.0
display:
  v: Basal cell carcinoma of lip

code:
  v: 2B62.Y
display:
  v: Other specified malignant neoplasms of other or unspecified parts of tongue

code:
  v: 1A36.1
display:
  v: Extraintestinal infections due to Entamoeba

code:
  v: 2D80.0
display:
  v: hepatic metastases

code:
  v: 2D80.1
display:
  v: intrahepatic gall ductal metastasis

code:
  v: 2B60.Y
display:
  v: Other specified malignant neoplasms of lip

code:
  v: 1B11.Z
display:
  v: CNS - [central nervous system] TB - [tuberculosis]

code:
  v: 1B12.3
display:
  v: Tuberculosis of pituitary gland

code:
  v: 2E00
display:
  v: renal pelvis metastasis

code:
  v: 2E02
display:
  v: ureteral metastasis

code:
  v: 1A36.00
display:
  v: Acute nondysenteric amebic enteritis

code:
  v: 2E01
display:
  v: urinary bladder metastasis

code:
  v: 1A36.01
display:
  v: Amoeboma of large intestine

code:
  v: 1A36.0Y
display:
  v: nondysenteric amebic diarrhoea

code:
  v: 3A00-3A03.Y
display:
  v: Nutritional or metabolic anaemias

code:
  v: 3A10-3A4Z
display:
  v: Haemolytic anaemias

code:
  v: 3A50
display:
  v: Thalassaemias

code:
  v: 2A33
display:
  v: Refractory anaemia with hemochromatosis

code:
  v: 1A13
display:
  v: Foodborne intoxication due to Bacillus cereus

code:
  v: 3B81
display:
  v: Acquired disorders of spleen

code:
  v: 3B8Z
display:
  v: splenopathy

code:
  v: 3B80
display:
  v: Congenital disorders of spleen

code:
  v: 2A21.0
display:
  v: Systemic mastocytosis

code:
  v: 1A1Y
display:
  v: Foodborne Vibrio parahaemolyticus intoxication

code:
  v: 2A21.1
display:
  v: Cutaneous mastocytosis

code:
  v: 1A60.3
display:
  v: Late congenital syphilitic polyneuropathy

code:
  v: 2A21.2
display:
  v: Mast cell sarcoma

code:
  v: 1A70.Z
display:
  v: Gonococcal genitourinary infection

code:
  v: 1A03
display:
  v: Intestinal infections due to Escherichia coli

code:
  v: 1A04
display:
  v: megacolon due to Clostridium difficile

code:
  v: 2A34
display:
  v: refractory anaemia with sideroblasts with transformation

code:
  v: 1A8Z
display:
  v: Sexually transmissible infections due to chlamydia, unspecified

code:
  v: 2B52.1
display:
  v: Ewing sarcoma of bone or articular cartilage of pelvis

code:
  v: 2A35
display:
  v: RAEB 2 - [Refractory anaemia with excess of blasts type 2]

code:
  v: 2B52.0
display:
  v: Ewing sarcoma of bone or articular cartilage of limbs

code:
  v: 2B52.2
display:
  v: Ewing sarcoma of bone or articular cartilage of ribs

code:
  v: 1A05
display:
  v: Colitis due to Yersinia enterocolitica

code:
  v: 1A72.3
display:
  v: Acute gonococcal pharyngitis

code:
  v: 1A72.4
display:
  v: Keratitis blennorrhagica

code:
  v: 1A11.1
display:
  v: Toxin-mediated infectious botulism

code:
  v: 2A02.1Z
display:
  v: Primary malignant neoplasm of vagus nerve

code:
  v: 1A11.Z
display:
  v: Disorders of the neuromuscular junction in botulism

code:
  v: 1A11.0
display:
  v: Foodborne Clostridium botulinum toxin intoxication

code:
  v: 1A61.3
display:
  v: Syphilitic alopecia

code:
  v: 1B1Z
display:
  v: Tuberculosis attributable to Mycobacterium tuberculosis

code:
  v: 1A61.4
display:
  v: Secondary syphilitic lymphadenitis

code:
  v: 2A20.3
display:
  v: Chronic eosinophilic leukaemia, not elsewhere classified

code:
  v: 2B51.0
display:
  v: Osseous sarcomas of bone and articular cartilage of mandible

code:
  v: 2B51.2
display:
  v: Osseous sarcomas of bone and articular cartilage of pelvic bones, sacrum and coccyx

code:
  v: 2B62.Z
display:
  v: primary malignant neoplasm of tongue

code:
  v: 2B51.1
display:
  v: Osteosarcoma of bone or articular cartilage of limbs

code:
  v: 1B12.4Y
display:
  v: Tuberculosis of other specified part of the musculoskeletal system

code:
  v: 1A60.4
display:
  v: Congenital syphilitic stigmata

code:
  v: 1B12.41
display:
  v: Tuberculosis of skeletal muscle

code:
  v: 2D60.3
display:
  v: Malignant neoplasm metastasis in axillary or arm lymph nodes by other or unspecified epithelial neoplasm

code:
  v: 1A61.5
display:
  v: latent syphilis, positive serology, early or less than 2 years after infection

code:
  v: 2D85
display:
  v: ileocecum metastasis

code:
  v: 1A60.5
display:
  v: Late congenital syphilis, latent

code:
  v: 2A50
display:
  v: Myeloid/lymphoid neoplasm associated with PDGFRA rearrangement

code:
  v: 2A52
display:
  v: Myeloid or lymphoid neoplasms with FGFR1 abnormalities

code:
  v: 1B12.40
display:
  v: Tuberculous rheumatism

code:
  v: 2A5Z
display:
  v: Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB or FGFR1, unspecified

code:
  v: 2D60.4
display:
  v: Malignant neoplasm metastasis in inguinal or leg lymph nodes by other or unspecified epithelial neoplasm

code:
  v: 2B62.10
display:
  v: Squamous cell carcinoma of lingual tonsil

code:
  v: 2B62.1Z
display:
  v: primary malignant neoplasm of lingual tonsil

code:
  v: 1A62.20
display:
  v: Late syphilitic chorioretinitis

code:
  v: 1A62.00
display:
  v: Asymptomatic neurosyphilis

code:
  v: 1A62.0Z
display:
  v: tertiary central nervous system syphilis

code:
  v: 1A62.22
display:
  v: Syphilitic gumma

code:
  v: 2D60.5
display:
  v: Iliac lymph gland metastasis

code:
  v: 1A62.01
display:
  v: Syphilitic paraplegia

code:
  v: 1A62.21
display:
  v: Syphilis, stage unspecified, of synovium

code:
  v: 2B60.Z
display:
  v: malignant neoplasm of lip, unspecified

code:
  v: 2D8Z
display:
  v: Malignant neoplasm metastasis in unspecified digestive system organ

code:
  v: 2B63.0
display:
  v: Squamous cell carcinoma of gum

code:
  v: 2D8Y
display:
  v: submandibular glandular metastasis

code:
  v: 2B63.Y
display:
  v: Malignant neoplasm of alveolar ridge mucosa

code:
  v: 2B63.Z
display:
  v: primary malignant neoplasm of gum

code:
  v: 1A36.10
display:
  v: amoebic hepatitis

code:
  v: 1A36.11
display:
  v: Amoebic abscess of lung and liver

code:
  v: 1A36.12
display:
  v: Amoebic ulcer of skin

code:
  v: 3B50-3B51
display:
  v: Fibrinolytic defects

code:
  v: 3B10-3B4Z
display:
  v: Coagulation defects

code:
  v: 3B60
display:
  v: Non-thrombocytopenic purpura

code:
  v: 2E04
display:
  v: Malignant neoplasm metastasis in soft tissue of abdominal wall

code:
  v: 2E03
display:
  v: Metastatic fracture of unspecified site

code:
  v: 1A36.0Z
display:
  v: Intestinal infections due to Entamoeba

code:
  v: 2E05
display:
  v: Malignant neoplasm metastasis in female reproductive system

code:
  v: 2B50.0
display:
  v: Chondrosarcoma of bone or articular cartilage of limbs

code:
  v: 2B50.1
display:
  v: Chondromatous sarcomas of bone and articular cartilage of pelvic bones, sacrum and coccyx

code:
  v: 2B50.2
display:
  v: Chondrosarcoma of bone or articular cartilage of ribs, sternum or clavicle

code:
  v: 1A70.00
display:
  v: Gonococcal lymphangitis of penis

code:
  v: 1A70.0Z
display:
  v: gonorrhoeal condyloma

code:
  v: 3A00
display:
  v: Iron deficiency anaemia

code:
  v: 1A70.0Y
display:
  v: Gonococcal vulvovaginitis

code:
  v: 3A02
display:
  v: Folate deficiency anaemia

code:
  v: 3A01
display:
  v: Megaloblastic anaemia due to vitamin B12 deficiency

code:
  v: 3A10-3A1Y
display:
  v: Congenital haemolytic anaemia

code:
  v: 3A20-3A2Z
display:
  v: Acquired haemolytic anaemia

code:
  v: 3A4Z
display:
  v: Haemolytic anaemias, unspecified

code:
  v: 2B71.0
display:
  v: Adenocarcinoma of oesophagogastric junction

code:
  v: 2B71.Z
display:
  v: primary malignant neoplasm of cardia of stomach

code:
  v: 3A50.1
display:
  v: Alpha-thalassaemia intellectual disability syndrome linked to chromosome 16

code:
  v: 3A50.0
display:
  v: Alpha thalassaemia

code:
  v: 3A50.2
display:
  v: Beta-thalassemia-X-linked thrombocytopenia syndrome

code:
  v: 2B70.1
display:
  v: Squamous cell carcinomas of overlapping lesion of oesophagus

code:
  v: 2B70.0
display:
  v: Adenocarcinoma of oesophagus

code:
  v: 1A1Z
display:
  v: food infection

code:
  v: 2B71.Y
display:
  v: Other specified malignant neoplasm of oesophagogastric junction

code:
  v: 2A36
display:
  v: 5 q- syndrome

code:
  v: 2B72.Y
display:
  v: metastatic gastric carcinoma [primary gastric carcinoma spreading elsewhere]

code:
  v: 2B72.0
display:
  v: Adenocarcinoma involving overlapping sites of stomach

code:
  v: 2B72.1
display:
  v: Gastrointestinal APUDomas

code:
  v: 2B70.Y
display:
  v: Metastatic oesophageal carcinoma [primary oesophageal carcinoma spreading elsewhere]

code:
  v: 3B81.1
display:
  v: acquired absence of spleen

code:
  v: 3B81.0
display:
  v: SANT - [Sclerosing angiomatoid nodular transformation]

code:
  v: 3B81.2
display:
  v: Degenerative diseases of the spleen

code:
  v: 2A20.4
display:
  v: primary polycythaemia

code:
  v: 2A21.00
display:
  v: Mast cell leukaemia in complete remission

code:
  v: 2A21.0Y
display:
  v: Lymphoadenopathic mastocytosis with eosinophilia

code:
  v: 2A21.3
display:
  v: Extracutaneous mastocytoma

code:
  v: 2A21.0Z
display:
  v: systemic tissue mast cell disease

code:
  v: 2A21.10
display:
  v: Maculopapular cutaneous mastocytosis

code:
  v: 2A21.1Z
display:
  v: Cutaneous mastocytosis

code:
  v: 3B80.0
display:
  v: Splenomegaly in storage diseases

code:
  v: 2A21.1Y
display:
  v: Pseudoxanthomatous nodular cutaneous mastocytosis

code:
  v: 1A60.Z
display:
  v: Late congenital syphilis

code:
  v: 1A03.0
display:
  v: Colitis in enteropathogenic Escherichia coli infection

code:
  v: 2A37
display:
  v: Myelodysplastic syndrome, unclassifiable

code:
  v: 1A03.1
display:
  v: Colitis in enterotoxigenic Escherichia coli infection

code:
  v: 1A03.2
display:
  v: Colitis in enteroinvasive Escherichia coli infection

code:
  v: 2B52.3
display:
  v: Malignant peripheral neuroectodermal tumour of cervix uteri

code:
  v: 2B52.Y
display:
  v: Extraosseous Ewing sarcoma

code:
  v: 2B52.Z
display:
  v: Ewing's sarcoma/peripheral neuroectodermal tumour [PNET]

code:
  v: 2A38
display:
  v: Refractory cytopenia of childhood

code:
  v: 1A72.Y
display:
  v: Gonococcal skin lesions

code:
  v: 2E65.1
display:
  v: Lobular carcinoma in situ of breast, pleomorphic subtype

code:
  v: 1A61.Y
display:
  v: Other specified early syphilis

code:
  v: 2E65.0
display:
  v: Lobular carcinoma in situ of right breast

code:
  v: 2E65.2
display:
  v: Intraductal carcinoma in situ of left breast

code:
  v: 2E66.Y
display:
  v: Squamous cell carcinoma in situ with questionable stromal invasion of unspecified site

code:
  v: 2E66.Z
display:
  v: Carcinoma in situ of other parts of cervix

code:
  v: 2E67
display:
  v: Carcinoma in situ of other or unspecified genital organs

code:
  v: 2E66.2
display:
  v: cervical intraepithelial neoplasia grade II

code:
  v: 2A20.5
display:
  v: Non mast cell myeloproliferative neoplasm, unclassifiable

code:
  v: 1A61.Z
display:
  v: general syphilis

code:
  v: 1A73
display:
  v: Disseminated infection due to Neisseria gonorrhoeae

code:
  v: 2B51.Y
display:
  v: Li-Fraumeni syndrome

code:
  v: 2B51.Z
display:
  v: osteogenic sarcoma

code:
  v: 1B12.4Z
display:
  v: Tuberculosis of the musculoskeletal system

code:
  v: 2D60.Y
display:
  v: Other specified malignant neoplasm metastasis in lymph node of a single region

code:
  v: 2A60.20
display:
  v: Acute myeloid leukemia and myelodysplastic syndromes related to topoisomerase type 2 inhibitor

code:
  v: 2A60.2Z
display:
  v: therapy-related myelodysplastic syndromes

code:
  v: 2A60.2Y
display:
  v: Other specified therapy-related myeloid neoplasms

code:
  v: 2A60.31
display:
  v: Acute myeloblastic leukaemia without maturation

code:
  v: 2A60.30
display:
  v: Minimally differentiated acute myeloblastic leukaemia

code:
  v: 2A60.40
display:
  v: Transient abnormal myelopoiesis

code:
  v: 2A60.32
display:
  v: Acute myeloblastic leukaemia with maturation

code:
  v: 2A60.41
display:
  v: Myeloid leukaemia associated with Down syndrome

code:
  v: 2A60.4Y
display:
  v: Other specified myeloid proliferation associated with Down syndrome

code:
  v: 2D60.Z
display:
  v: Malignant neoplasm metastasis in lymph node of a single region

code:
  v: 1B21.20
display:
  v: Buruli ulcer

code:
  v: 1B21.2Z
display:
  v: Atypical mycobacterial infection of the skin

code:
  v: 1B21.2Y
display:
  v: Cutaneous Mycobacterium kansasii infection

code:
  v: 2B64.0
display:
  v: Squamous cell carcinoma of floor of mouth

code:
  v: 2B64.Z
display:
  v: primary malignant neoplasm of floor of mouth

code:
  v: 2B64.Y
display:
  v: Other specified malignant neoplasm of floor of mouth

code:
  v: 1A62.2Z
display:
  v: Symptomatic late syphilis of other sites

code:
  v: 1A62.2Y
display:
  v: Late syphilitic peritonitis

code:
  v: 1A62.Y
display:
  v: Syphilis positive serology, late or 2 years or more after infection

code:
  v: 2B65
display:
  v: Malignant neoplasms of palate

code:
  v: 2B66
display:
  v: Malignant neoplasms of other or unspecified parts of mouth

code:
  v: 1A36.1Y
display:
  v: Amoebic vulvovaginitis

code:
  v: 3B50
display:
  v: Inherited fibrinolytic defects

code:
  v: 3B51
display:
  v: Fibrinolytic disorder due to administration of other drugs

code:
  v: 3B10-3B1Z
display:
  v: Congenital or constitutional haemorrhagic condition

code:
  v: 3B20-3B2Y
display:
  v: Haemorrhagic diseases due to acquired coagulation factor defects

code:
  v: 3B4Z
display:
  v: coagulopathy NOS

code:
  v: 2E06
display:
  v: Malignant neoplasm metastasis in penis

code:
  v: 2E05.Z
display:
  v: Malignant neoplasm metastasis in female reproductive system

code:
  v: 2E05.0
display:
  v: Secondary mucinous adenocarcinoma of ovary

code:
  v: 2E05.Y
display:
  v: vaginovesical septum metastasis

code:
  v: 2E07
display:
  v: suprarenal gland metastasis

code:
  v: 1B12.7
display:
  v: Tuberculous ascites

code:
  v: 2B50.Z
display:
  v: chondrosarcoma NOS

code:
  v: 2B50.Y
display:
  v: Chondromatous sarcomas of bone and articular cartilage of vertebral column

code:
  v: 3A00.0
display:
  v: Acquired iron deficiency anaemia due to blood loss

code:
  v: 3A00.1
display:
  v: Iron deficiency anaemia due to malnutrition

code:
  v: 3A00.2
display:
  v: Acquired iron deficiency anaemia due to coeliac disease

code:
  v: 1A06
display:
  v: Colitis due to Campylobacter

code:
  v: 3A02.0
display:
  v: Hereditary folate deficiency anaemia

code:
  v: 3A02.2
display:
  v: Acquired megaloblastic anaemia associated with psoriasis

code:
  v: 3A02.1
display:
  v: megaloblastic anaemia due to poor nutrition

code:
  v: 3A01.1
display:
  v: Nutritional vitamin B12 deficiency due to maternal vitamin B12 deficiency in breast-fed infants

code:
  v: 3A01.0
display:
  v: Anaemia due to selective hereditary vitamin B12 malabsorption with proteinuria

code:
  v: 3A01.2
display:
  v: vegan anaemia NOS

code:
  v: 3A1Y
display:
  v: congenital heinz body haemolytic anaemia

code:
  v: 3A10
display:
  v: Hereditary haemolytic anaemia

code:
  v: 3A20
display:
  v: Acquired haemolytic anaemia, immune

code:
  v: 3A21
display:
  v: Acquired haemolytic anaemia, non-immune

code:
  v: 3A2Z
display:
  v: haemoglobinaemia

code:
  v: 3A50.3
display:
  v: Haemoglobin Lepore

code:
  v: 2B70.Z
display:
  v: Metastatic oesophageal cancer [primary oesophageal cancer spreading elsewhere]

code:
  v: 2B70.00
display:
  v: Barrett adenocarcinoma

code:
  v: 2B70.0Z
display:
  v: oesophageal adenocarcinoma

code:
  v: 2B70.0Y
display:
  v: Adenocarcinoma involving overlapping sites of oesophagus

code:
  v: 2B80-2C0Z
display:
  v: Malignant neoplasms of intestine

code:
  v: 2A3Y
display:
  v: Refractory anaemia with excess blasts in childhood

code:
  v: 2B72.Z
display:
  v: cancer of pylorus of stomach

code:
  v: 3B81.5
display:
  v: Splenic cyst or pseudocyst

code:
  v: 3B81.3
display:
  v: Nontraumatic laceration or rupture of spleen

code:
  v: 3B81.4
display:
  v: Splenosis

code:
  v: 2A20.Y
display:
  v: Other specified non mast cell myeloproliferative neoplasms

code:
  v: 2A21.Y
display:
  v: Other specified mastocytosis

code:
  v: 2A21.Z
display:
  v: malignant mastocytosis

code:
  v: 1A03.3
display:
  v: Colitis in enterohaemorrhagic Escherichia coli infection

code:
  v: 2A3Z
display:
  v: preleukaemic syndrome

code:
  v: 1A03.Y
display:
  v: EAEC - [Enteroaggregative Escherichia coli] infection

code:
  v: 1A03.Z
display:
  v: Escherichia coli enteritis, not otherwise specified

code:
  v: 2B53
display:
  v: Fibroblastic or myofibroblastic tumour, primary site

code:
  v: 2E65.3
display:
  v: Ductal carcinoma in situ of breast, comedo subtype

code:
  v: 2E65.4
display:
  v: lobular with intraductal carcinoma in situ

code:
  v: 2A20.02
display:
  v: Chronic myelogenous leukaemia, t(9:22)(q34; q11)

code:
  v: 2A20.01
display:
  v: Chronic myelogenous leukaemia, Philadelphia chromosome (Ph1) positive

code:
  v: 2A20.00
display:
  v: Chronic myelogenous leukaemia with blast crisis

code:
  v: 2A20.Z
display:
  v: Non mast cell myeloproliferative neoplasms

code:
  v: 2E68
display:
  v: carcinoma in situ of urinary bladder

code:
  v: 2B54
display:
  v: Undifferentiated pleomorphic sarcoma, primary site

code:
  v: 1B12.Y
display:
  v: Tuberculosis of adenoids, with bacteriological and histological confirmation

code:
  v: 2A60.5
display:
  v: agranular CD4+ NK leukaemia

code:
  v: 2A60.33
display:
  v: Acute myelomonocytic leukaemia in complete remission

code:
  v: 2A60.4Z
display:
  v: Myeloid proliferation associated with Down syndrome

code:
  v: 2A60.34
display:
  v: AML M5b

code:
  v: 2A60.35
display:
  v: Acute erythroid leukaemia in complete remission

code:
  v: 2E2Z
display:
  v: Secondary carcinoma of unspecified site

code:
  v: 2B67
display:
  v: Malignant neoplasms of parotid gland

code:
  v: 1A62.Z
display:
  v: late tertiary syphilis

code:
  v: 1A07
display:
  v: Typhoid fever

code:
  v: 3B10
display:
  v: Hereditary factor VIII deficiency

code:
  v: 3B50.0
display:
  v: Congenital alpha2 antiplasmin deficiency

code:
  v: 3B11
display:
  v: Hereditary factor IX deficiency

code:
  v: 3B50.Y
display:
  v: Excessive release of tPA - [tissue-type plasminogen activator]

code:
  v: 3B50.1
display:
  v: Congenital PAI-1 - [plasminogen activator inhibitor type 1] deficiency

code:
  v: 3B12
display:
  v: Von Willebrand disease type 3

code:
  v: 2E08
display:
  v: Malignant metastasis neoplasm involving skin of abdominal wall

code:
  v: 3A50.02
display:
  v: Alpha thalassaemia intermedia

code:
  v: 3A50.00
display:
  v: Heterozygous non-deletional alpha thalassaemia (αTα/αα and ααT/αα included)

code:
  v: 3A50.01
display:
  v: Haemoglobin Constant Spring

code:
  v: 2E09
display:
  v: Malignant neoplasm metastasis in peripheral nervous system

code:
  v: 2E0Y
display:
  v: orbit metastasis

code:
  v: 2B55
display:
  v: Rhabdomyosarcoma, primary site

code:
  v: 3A00.3
display:
  v: Acquired iron deficiency anaemia due to increased requirement in pregnancy

code:
  v: 3A00.Y
display:
  v: microcytic anaemia NOS

code:
  v: 3A02.3
display:
  v: Megaloblastic anaemia due to decreased intestinal absorption of folate

code:
  v: 3A02.4
display:
  v: megaloblastic anaemia due to drug-induced folate deficiency

code:
  v: 1A08
display:
  v: Colitis due to paratyphoid fever C

code:
  v: 3A01.3
display:
  v: Vitamin B12 deficiency anaemia due to intrinsic factor deficiency

code:
  v: 3A02.Y
display:
  v: Tropical macrocytic anaemia

code:
  v: 3A20.2
display:
  v: Autoimmune haemolytic anaemia, mixed type, cold and warm

code:
  v: 3A01.4
display:
  v: Acquired megaloblastic anaemia due to vitamin B12 deficiency secondary to intestinal disease

code:
  v: 3A20.0
display:
  v: acute Lederer haemolytic anaemia

code:
  v: 3A10.1
display:
  v: Haemolytic anaemia due to adenosine deaminase excess

code:
  v: 3A20.1
display:
  v: cold hemagglutinin disease

code:
  v: 3A10.0
display:
  v: Haemolytic anaemias due to hexose monophosphate shunt or glutathione metabolism anomalies

code:
  v: 3A21.2
display:
  v: Glomerular disorders in haemolytic uraemic syndrome

code:
  v: 3A10.2
display:
  v: Hereditary pyropoikilocytosis

code:
  v: 3A21.1
display:
  v: Neoplastic microangiopathic haemolytic anaemia

code:
  v: 3A21.0
display:
  v: nocturnal paroxysmal haemoglobinaemia

code:
  v: 3A50.4
display:
  v: Hereditary persistence of fetal haemoglobin, non-deletional

code:
  v: 2E65.5
display:
  v: Paget disease of nipple

code:
  v: 2E67.0
display:
  v: endometrial carcinoma in situ

code:
  v: 2E67.1
display:
  v: vulvar carcinoma in situ

code:
  v: 2E67.2
display:
  v: Carcinoma in situ of vagina

code:
  v: 2C10
display:
  v: Malignant neoplasm of pancreas

code:
  v: 3B81.51
display:
  v: Epithelial cyst of spleen

code:
  v: 3B81.5Y
display:
  v: Other specified splenic cyst

code:
  v: 3B81.50
display:
  v: Pseudocyst of spleen

code:
  v: 3B81.7
display:
  v: Infection of spleen

code:
  v: 3B81.6
display:
  v: Subcapsular splenic haemorrhage

code:
  v: 2B65.0
display:
  v: Salivary gland-type carcinoma of palate

code:
  v: 2B65.1
display:
  v: Squamous cell carcinoma of palate

code:
  v: 2B65.Y
display:
  v: Carcinoma of palate

code:
  v: 2A61
display:
  v: Mixed phenotype acute leukaemias, T and myeloid, not elsewhere classified

code:
  v: 1A09
display:
  v: Infections due to other Salmonella

code:
  v: 2B66.0
display:
  v: Squamous cell carcinoma of other or unspecified parts of mouth

code:
  v: 2B53.0
display:
  v: fibromyxosarcoma of unspecified site

code:
  v: 2B53.1
display:
  v: Fibroblastic or myofibroblastic tumour of skin

code:
  v: 2B53.Y
display:
  v: pigmented dermatofibrosarcoma

code:
  v: 2B66.Y
display:
  v: Other specified malignant neoplasms of other or unspecified parts of mouth

code:
  v: 2B66.Z
display:
  v: primary malignant neoplasm of oral cavity

code:
  v: 3B21
display:
  v: Haemorrhagic disorder due to circulating anticoagulants or coagulation factors inhibitors

code:
  v: 3B22
display:
  v: Acquired factor XIII deficiency

code:
  v: 3B20
display:
  v: acquired fibrinogenopenia

code:
  v: 2E65.Y
display:
  v: Solid papillary carcinoma in situ of breast

code:
  v: 2E65.Z
display:
  v: Breast cancer in situ

code:
  v: 2A20.03
display:
  v: Naegeli-type monocytic leukaemia

code:
  v: 2A20.0Y
display:
  v: chronic myeloid leukaemia, BCR-ABL-positive in complete remission

code:
  v: 2A20.0Z
display:
  v: chronic myeloid leukaemia, BCR-ABL-positive without mention of remission

code:
  v: 2E69
display:
  v: Carcinoma in situ of other or unspecified urinary organs

code:
  v: 2B54.0
display:
  v: malignant fibrous histiocytoma of unspecified site

code:
  v: 2B54.Y
display:
  v: Undifferentiated pleomorphic sarcoma, other specified primary site

code:
  v: 2B54.1
display:
  v: Undifferentiated pleomorphic sarcoma of retroperitoneum or peritoneum

code:
  v: 1A81.Y
display:
  v: Chlamydial colitis

code:
  v: 1A81.1
display:
  v: Male chlamydial pelviperitonitis

code:
  v: 2A60.Y
display:
  v: Other specified acute myeloid leukaemias and related precursor neoplasms

code:
  v: 1A81.0
display:
  v: Chlamydial cervicitis

code:
  v: 2A60.Z
display:
  v: Acute myeloid leukaemias and related precursor neoplasms

code:
  v: 2A60.36
display:
  v: Acute megakaryoblastic leukaemia in complete remission

code:
  v: 2A60.37
display:
  v: Acute basophilic leukaemia

code:
  v: 1B41.1
display:
  v: Acute rheumatic endocarditis

code:
  v: 1B41.0
display:
  v: acute rheumatic bacterial pericardium inflammation

code:
  v: 2A60.38
display:
  v: Acute myelofibrosis in complete remission

code:
  v: 1B41.2
display:
  v: acute rheumatic toxic myocarditis

code:
  v: 1A07.Z
display:
  v: enteric fever NOS

code:
  v: 1A07.0
display:
  v: typhoperitonitis

code:
  v: 1A07.Y
display:
  v: Typhoid colitis

code:
  v: 3A00.01
display:
  v: chronic haemorrhagic anaemia

code:
  v: 3A00.0Z
display:
  v: haemorrhagic anaemia

code:
  v: 3B10.Y
display:
  v: Other specified hereditary factor VIII deficiency

code:
  v: 3B10.1
display:
  v: Hereditary factor VIII deficiency with anti-factor VIII inhibitor

code:
  v: 3B10.0
display:
  v: Symptomatic form of haemophilia A in female carriers

code:
  v: 3B50.Z
display:
  v: Inherited fibrinolytic defects

code:
  v: 3B11.Y
display:
  v: Other specified hereditary factor IX deficiency

code:
  v: 3B11.Z
display:
  v: intravascular clotting defect

code:
  v: 3B11.0
display:
  v: Symptomatic form of haemophilia B in female carriers

code:
  v: 3A50.03
display:
  v: Haemoglobin Bart hydrops fetalis

code:
  v: 3A50.0Y
display:
  v: Alpha thalassaemia myelodysplastic syndrome

code:
  v: 3A50.0Z
display:
  v: alpha thalassaemia syndrome

code:
  v: 2B80
display:
  v: Malignant neoplasms of small intestine

code:
  v: 2B81
display:
  v: Malignant neoplasms of appendix

code:
  v: 2B90-2B9Y
display:
  v: Malignant neoplasms of large intestine

code:
  v: 1A94
display:
  v: Anogenital herpes simplex infection

code:
  v: 2B55.2
display:
  v: Rhabdomyosarcoma of male genital organs

code:
  v: 2B55.0
display:
  v: Rhabdomyosarcoma of the oral cavity or pharynx

code:
  v: 2B55.1
display:
  v: Alveolar rhabdomyosarcoma

code:
  v: 3A00.Z
display:
  v: Fe - [iron] deficiency anemia NOS

code:
  v: 3A02.Z
display:
  v: Folic acid deficiency anaemia NOS

code:
  v: 3A01.5
display:
  v: Megaloblastic anaemia due to drug-induced vitamin B12 deficiency

code:
  v: 3A20.3
display:
  v: Donath-Landsteiner syndrome

code:
  v: 3A10.3
display:
  v: Familial pseudohyperkalaemia, Cardiff type

code:
  v: 1A0Y
display:
  v: Neonatal bacterial intestinal infection

code:
  v: 3A10.0Z
display:
  v: anaemia due to other disorders of glutathione metabolism

code:
  v: 3A10.00
display:
  v: anaemia due to haemolytic nonspherocytic (hereditary), type 1

code:
  v: 3A10.0Y
display:
  v: anaemia due to 6-phosphogluconate dehydrogenase deficiency

code:
  v: 3A21.Y
display:
  v: Atypical haemolytic uraemic syndrome with anti-factor H antibodies

code:
  v: 3A50.Y
display:
  v: Thalassaemia minor

code:
  v: 2E67.3
display:
  v: Carcinoma in situ of other or unspecified female genital organs

code:
  v: 2E67.2Z
display:
  v: Squamous cell carcinoma in situ of vagina

code:
  v: 2E67.22
display:
  v: severe vaginal dysplasia, NEC

code:
  v: 2E67.2Y
display:
  v: Other specified carcinoma in situ of vagina

code:
  v: 3B81.5Z
display:
  v: Splenic cyst or pseudocyst

code:
  v: 2C11
display:
  v: Malignant neoplasms of other or ill-defined digestive organs

code:
  v: 3B81.71
display:
  v: splenic abscess

code:
  v: 3B81.7Y
display:
  v: Other specified infection of spleen

code:
  v: 3B81.70
display:
  v: septic spleen

code:
  v: 2B67.1
display:
  v: Squamous cell carcinoma of parotid gland

code:
  v: 2B67.0
display:
  v: Acinar cell carcinoma of parotid gland

code:
  v: 2B67.Y
display:
  v: Other specified malignant neoplasms of parotid gland

code:
  v: 2B65.Z
display:
  v: malignant neoplasm of upper or lower labial sulcus

code:
  v: 1A09.Y
display:
  v: Pneumonia due to salmonella infection

code:
  v: 1A09.Z
display:
  v: Sepsis due to Salmonella infection with septic shock

code:
  v: 2A70-2A7Z
display:
  v: Precursor lymphoid neoplasms

code:
  v: 1A09.0
display:
  v: salmonellosis

code:
  v: 2B53.Z
display:
  v: Fibroblastic or myofibroblastic tumour, primary site

code:
  v: 2B68
display:
  v: Malignant neoplasms of submandibular or sublingual glands

code:
  v: 3A01.Y
display:
  v: Addison anaemia

code:
  v: 3B2Y
display:
  v: Acquired stable factor deficiency

code:
  v: 2E6A
display:
  v: Carcinoma in situ of the eye or ocular adnexa

code:
  v: 2A80-2A8Z
display:
  v: Mature B-cell neoplasms

code:
  v: 2B54.Z
display:
  v: Undifferentiated pleomorphic sarcoma, primary site

code:
  v: 2E6B
display:
  v: Carcinoma in situ of thyroglossal duct

code:
  v: 1A81.Z
display:
  v: other sexually transmitted chlamydial diseases

code:
  v: 1B41.10
display:
  v: Rheumatic aortitis

code:
  v: 2A60.39
display:
  v: Myeloid sarcoma in complete remission

code:
  v: 1B41.1Z
display:
  v: Acute rheumatic valvulitis

code:
  v: 2A60.3Y
display:
  v: Acute myeloid leukaemia, NOS by criteria of other types in complete remission

code:
  v: 1B41.Y
display:
  v: Acute rheumatic coronary arteritis

code:
  v: 1B41.1Y
display:
  v: Active or acute tricuspid endocarditis

code:
  v: 1B41.Z
display:
  v: acute RHD - [rheumatic heart disease]

code:
  v: 1A0Z
display:
  v: Phlegmonous colitis

code:
  v: 3B10.Z
display:
  v: Deficiency factor VIII with functional defect

code:
  v: 3B61
display:
  v: Thrombophilia

code:
  v: 3A01.3Z
display:
  v: Acquired megaloblastic anaemias due to vitamin B12 deficiency secondary to intrinsic factor deficiency

code:
  v: 3A01.30
display:
  v: Pernicious anaemia associated with other autoimmune disorders

code:
  v: 3A01.3Y
display:
  v: Vitamin B12 deficiency anaemia associated with total gastrectomy

code:
  v: 3A21.Z
display:
  v: acquired haemolytic anaemia, non-immune NOS

code:
  v: 3A50.Z
display:
  v: thalassemia variants

code:
  v: 2E67.11
display:
  v: Extramammary Paget disease of vulva

code:
  v: 2E67.12
display:
  v: DVIN [Differentiated vulvar intraepithelial neoplasia]

code:
  v: 2E67.13
display:
  v: High grade squamous intraepithelial lesion of vulva NOS

code:
  v: 2C10.0
display:
  v: Intraductal papillary-mucinous carcinoma of pancreas

code:
  v: 2C10.Y
display:
  v: Pancreatoblastoma

code:
  v: 2C10.1
display:
  v: Increased secretion from endocrine pancreas of pancreatic polypeptide

code:
  v: 1A94.1
display:
  v: Herpetic proctitis

code:
  v: 1A94.0
display:
  v: Herpes simplex infection of male genital tract NOS

code:
  v: 1A94.Z
display:
  v: anogenital HSV - [herpes simplex virus] infection

code:
  v: 3B81.8
display:
  v: Torsion of spleen

code:
  v: 2B55.Y
display:
  v: Myosarcoma of overlapping lesion of corpus uteri

code:
  v: 2B55.Z
display:
  v: Rhabdomyosarcoma, primary site

code:
  v: 3A03
display:
  v: Other nutritional or metabolic anaemias

code:
  v: 3B21.0
display:
  v: Haemorrhage due to thrombin inhibitor other than heparin

code:
  v: 3B21.1
display:
  v: Haemorrhage due to factor Xa inhibitor

code:
  v: 3B21.Y
display:
  v: Haemorrhagic disorder due to increase in anti-XIa

code:
  v: 3A01.Z
display:
  v: Megaloblastic anaemia due to vitamin B12 deficiency

code:
  v: 3A20.4
display:
  v: Lymphocyte passenger syndrome, following organ transplantation

code:
  v: 3A10.Y
display:
  v: Atypical haemolytic uraemic syndrome with thrombomodulin anomaly

code:
  v: 2E67.4
display:
  v: PIN - [penile intraepithelial neoplasia]

code:
  v: 2E67.5
display:
  v: carcinoma in situ prostate

code:
  v: 3B81.9
display:
  v: fibrotic spleen

code:
  v: 3B81.7Z
display:
  v: interstitial splenitis

code:
  v: 1A95
display:
  v: Anogenital warts

code:
  v: 2B67.Z
display:
  v: primary malignant neoplasm of parotid gland

code:
  v: 2A60.3Z
display:
  v: AML - [Acute myeloid leukaemia]

code:
  v: 2B69
display:
  v: Malignant neoplasms of tonsil

code:
  v: 2A70
display:
  v: Precursor B-lymphoblastic neoplasms

code:
  v: 2A7Z
display:
  v: Precursor lymphoid neoplasms, unspecified